Ana R. Freitas is one of the two awardees of the international 2018 Travel Awards promoted by the Pathogens journal
Ana R. Freitas, Post-doc in the BacT-drugs Lab, at UCIBIO in Faculdade de Farmácia do Porto, was awarded the 2018 Travel Award promoted by Pathogens. An Evaluation Committee organized by Pathogens Editorial Board attributed Travel Awards for two young investigators to support attending a conference in 2018 (800 CHF/720 EUR).
Nano4 Global awarded € 1.4 million to develop nanodiagnostics for tuberculosis detection
Nano4Global has been awarded 1.4 million euros in funding through the Horizon 2020 SME Instrument- Phase 2. The funding will help the company to develop nanodiagnostics for tuberculosis detection. The colorimetric test developed by Nano4 Global, based on nanotecnologies, will allow the tuberculosis diagnostic in 90 minutes instead of the current test that takes 3 days for disease detection.
Pedro Viana Baptista's project distinguished by Gilead GÉNESE Program
Tuberculosis (TB) is the main cause of death among HIV/AIDS patients worldwide. One of the main hurdles to effectively tackle this issue is the difficulty posed by the accurate molecular diagnostics of TB in HIV+ individuals. Also, the WHO recommends that all TB patients be screened for HIV infection. As such, there is a global need for fast and accurate detection platforms for TB/HIV that are non-invasive and might reduce the economic burden of current molecular assays.
